EUVIMEDEUVIMED entdecken
Crossref

Development of an in-house control standard for quantitative polymerase chain reaction–based diagnosis of leprosy

Selfu Girma iD, Mesfin Tafesse Gemeda iD, Adugna Abdi Woldesemayat iD, Kidist Bobosha iD, Endalamaw Gadisa iD

Laboratory Medicine · 03.04.2026 · 57 (3)

DOI: 10.1093/labmed/lmag020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Laboratory Medicine, online erschienen am 30.04.2026. Verfasst von Selfu Girma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Communicable and Non communicable Diseases Research Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia. Hauptthemen laut MEDLINE: Leprosy, Mycobacterium leprae, Real-Time Polymerase Chain Reaction. Die Arbeit nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

To develop an in-house reference control DNA standard targeting the RLEP region of Mycobacterium leprae for use in quantitative polymerase chain reaction (qPCR) diagnostics, aiming to reduce dependence on animal models and external sources.

Method

Previously characterized DNA samples from patients with leprosy were used to amplify and sequence the 450-base pair RLEP region. A specific 131-base pair segment within this region was targeted for qPCR assay development. The amplified products were purified; sequenced using Illumina next-generation sequencing technology; and validated through bioinformatics analyses, including Basic Local Alignment Search Tool (BLAST; National Institutes of Health) alignment and copy number assessment.

Results

The consensus sequence aligned perfectly with the known RLEP region. The BLAST analysis revealed 37 copies of the target sequence throughout the genome, confirming the sequence’s utility as a sensitive diagnostic marker. The qPCR assay successfully detected the target in both reference and clinical samples, with melting curve analysis indicating high specificity.

Discussion

An in-house M leprae RLEP control standard was successfully developed that provides a reliable, ethical, and resource-efficient alternative to traditional animal-derived controls for leprosy diagnosis using qPCR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeprosyMycobacterium lepraeReal-Time Polymerase Chain ReactionHumansDNA, BacterialReference StandardsSensitivity and SpecificityHigh-Throughput Nucleotide Sequencing

Stichwörter der Autor:innen

Mycobacterium lepraeNGSRLEPin-house reference DNAmolecular diagnosisnext-generation sequencingquantitative PCR

Substanzen

DNA, Bacterial

Autor:innen und Institutionen

  • Communicable and Non communicable Diseases Research Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
  • Biotechnology and Bioprocess Centre of Excellence, Addis Ababa Science and Technology University, Addis Ababa, Ethiopia.

ORCID-Profile: Selfu Girma, Mesfin Tafesse Gemeda, Adugna Abdi Woldesemayat, Kidist Bobosha, Endalamaw Gadisa

Zitieren

APA

Girma, S., Gemeda, M. T., Woldesemayat, A. A., Bobosha, K., & Gadisa, E. (2026). Development of an in-house control standard for quantitative polymerase chain reaction–based diagnosis of leprosy. Laboratory Medicine, 57(3). https://doi.org/10.1093/labmed/lmag020

Vancouver

Girma S, Gemeda MT, Woldesemayat AA, Bobosha K, Gadisa E. Development of an in-house control standard for quantitative polymerase chain reaction–based diagnosis of leprosy. Laboratory Medicine. 2026;57(3). doi:10.1093/labmed/lmag020

BibTeX
@article{Girma2026,
  author = {Girma, Selfu and Gemeda, Mesfin Tafesse and Woldesemayat, Adugna Abdi and Bobosha, Kidist and Gadisa, Endalamaw},
  title = {Development of an in-house control standard for quantitative polymerase chain reaction–based diagnosis of leprosy},
  journal = {Laboratory Medicine},
  year = {2026},
  volume = {57},
  number = {3},
  doi = {10.1093/labmed/lmag020}
}
Kostenlos starten →